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Analysis of placentas infected with human cytomegalovirus (CMV) suggested that viral transmission could involve
differentiating/invasive cytotrophoblasts in villi that attach the placenta to the uterine wall. To parse the cellular components
in this process, we developed a coculture system of polarized uterine microvascular endothelial cell (UtMVEC) infection with
an endothelial cell–tropic pathogenic strain of CMV. Then we evaluated the potential role of neutrophils and endothelial cells
in the spread of infection to differentiating cytotrophoblasts. As shown by immunocytochemistry and analysis of viral
replication, CMV preferentially infected endothelial cells via apical membranes and disrupted cell junction proteins, thereby
altering paracellular permeability and cell polarity. Neutralizing antibodies to CMV glycoprotein B, an envelope component
that facilitates virion penetration, blocked plaque formation in polarized UtMVEC. Neutrophils transmitted CMV infection to
UtMVEC, which in turn infected cytotrophoblasts. However, neutrophils did not directly infect cytotrophoblasts. These
findings implicate endothelial cells from the uterine microvasculature as a potential source for CMV infection of endovascular
cytotrophoblasts of the anchoring villi. Possibly the cytokine/chemokine milieu in the pregnant uterus could attract immuneINTRODUCTION
Human cytomegalovirus (CMV) is the leading cause of
congenital viral infection, affecting about 1% of newborns
in the United States (reviewed in Britt, 1999). Prenatal
transmission can occur at any time during gestation as a
consequence of primary maternal CMV infection, rein-
fection with different viral strains, or reactivation of latent
virus (Ahlfors et al., 1999; Boppana et al., 1999, 2001;
Fowler et al., 1992; Stagno et al., 1986). Recently, we
published data in strong support of the concept that
placental infection precedes viral transmission to the
fetus (Fisher et al., 2000), confirming suggestions in pre-
vious reports (Benirschke et al., 1974; Griffiths and Ba-
boonian, 1984). Seroconversion rates and restriction-en-
donuclease analyses of CMV strains indicate that het-
erosexual activity (Chandler et al., 1985, 1987; Fowler and
Pass, 1991; Handsfield et al., 1985) and contact with
young children (Hutto et al., 1985; Pass et al., 1987) are
key sources of infection in women of child-bearing age.
The importance of the placenta in transmission of
CMV to the fetus is also suggested by the unusual
anatomy of the maternal–fetal interface (Fig. 1) (reviewed
1 To whom correspondence and reprint requests should be ad-in Cross et al., 1994; Damsky and Fisher, 1998). During
placentation, specialized epithelial stem cells called cy-
totrophoblasts differentiate into the specialized tropho-
blast population of floating and anchoring chorionic villi.
Cytotrophoblasts in the floating villi differentiate by fus-
ing into multinucleated syncytiotrophoblasts that cover
the villus surface and are in direct contact with maternal
blood (Fig. 1A). These cells transfer substances from
maternal blood across the placenta to the embryo/fetus.
Cytotrophoblasts in the anchoring villi remain as single
cells that aggregate into columns and invade the endo-
metrium and the first third of the myometrium (interstitial
invasion). They also breach portions of maternal arte-
rioles that span these regions (endovascular invasion)
(Fig. 1B). By midgestation, invasive cytotrophoblasts
have completely replaced the endothelial lining and
much of the smooth muscle wall of these arteries, form-
ing a hybrid vasculature composed of fetal and maternal
cells.
During placental development, an unusual molecular
differentiation program is initiated that is required for
normal pregnancy (Cross et al., 1994; Damsky and
Fisher, 1998; Fisher and Damsky, 1993; Norwitz et al.,
2001). Syncytiotrophoblasts that cover floating villi up-
regulate their expression of many molecules that arecells that infect endothelial cells in hybrid fetal–maternal vessels. In turn, these cells could infect endovascular cytotropho-
blasts, one possible initiation point of a cascade that results in retrograde placental CMV infection. © 2002 Elsevier Science (USA)
doi:10.1006/viro.2002.1661dressed at University of California San Francisco, San Francisco, Cal-
ifornia 94143-0512. Fax: 415-502-7338. E-mail: pereira@itsa.ucsf.edu.involved in transferring substances across the placenta.
For example, they express the neonatal immunoglobulin
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FIG. 1. Diagram of the fetal–maternal interface near the end of the first trimester of human pregnancy (10 weeks of gestational age). (A) Longitudinal
section that includes a floating and an anchoring chorionic villus. The anchoring villus (AV) functions as a bridge between the fetal and maternal
compartments, whereas the floating villus (FV), containing macrophages (Hofbauer cells) and fetal blood vessels, is bathed by maternal blood.
Cytotrophoblasts in AV (Zone I) form cell columns that attach to the uterine wall (Zones II and III). Cytotrophoblasts then invade the uterine interstitium
(decidua and first third of the myometrium: Zone IV) and maternal vasculature (Zone V), thereby anchoring the fetus to the mother and accessing the
maternal circulation. Zone designations mark areas in which cytotrophoblasts have distinct patterns of stage-specific antigen expression, including
integrins and HLA-G. Decidual granular leukocytes (DGLs) and maternal blood and fetal capillaries in villus cores are indicated. Areas proposed as
sites of natural CMV transmission to the placenta in utero are numbered 1, 2, and 3. (B) Diagram of a uterine (spiral) artery in which endovascular
invasion is in progress (10–20 weeks of gestation). Endometrial and then myometrial segments of spiral arteries are modified progressively. In fully
modified regions (a) the vessel diameter is large. Cytotrophoblasts (CTBs) are present in the lumen and occupy the entire surface of the vessel wall.
A discrete muscular layer (tunica media) is not evident. In partially modified vessel segments (b), cytotrophoblasts and maternal endothelium occupy
discrete regions of the vessel wall. In areas of intersection, cytotrophoblasts appear to lie deep to the endothelium and in contact with the vessel
wall. (c) Unmodified vessel segments in the myometrium. Vessel segments in the superficial third of the myometrium will become modified when
endovascular invasion reaches its fullest extent (about midgestation), while deeper segments of the same artery will retain their normal structure.
(Modified with permission from Zhou et al., 1997).
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G (IgG) Fc receptor, which binds and transports maternal
IgG to the fetus (Leach et al., 1996; Simister et al., 1996;
Story et al., 1994). Invading cytotrophoblasts in the an-
choring villi begin to express adhesion molecules (e.g.,
integrin-11) and proteinases (e.g., matrix metallopro-
teinase-9) required for invasion, as well as molecules
that are likely to play a role in maternal immune toler-
ance, such as the nonclassical major histocompatibility
complex class Ib molecule HLA-G (Kovats et al., 1990;
McMaster et al., 1995), the cytokine interleukin-10 (Roth
and Fisher, 1999), and the chemokine macrophage inhib-
itory protein-1, which attracts monocytes and natural
killer cells that populate the decidua (Allan et al., 1999;
Drake et al., 2001; Lanier, 2001). Invading cytotropho-
blasts also transform their adhesion receptor phenotype
to resemble that of the endothelial cells they replace. For
example, they express v3-integrin, a marker of endo-
thelium, and vascular endothelial cadherin (VE-caderin)
(Damsky and Fisher, 1998)
Human cytotrophoblasts are fully permissive for CMV
infection in vitro and play a central role in viral transmis-
sion to the fetus (Fisher et al., 2000; Halwachs-Baumann
et al., 1998; Hemmings et al., 1998). After CMV infection
of purified differentiating cytotrophoblasts from first-tri-
mester placentas, we found that 11-integrin and
HLA-G were downregulated, and the cells were impaired
in their ability to invade Matrigel in an in vitro invasion
assay (Fisher et al., 2000). The cellular organization of
the maternal–fetal interface suggests at least three sites
of infection (see Fig. 1): direct dissemination from (site 1)
maternal blood cells to cytotrophoblasts in floating villi,
(site 2) infected macrophages among decidual granular
leukocytes to differentiating/invasive cytotrophoblasts in
the decidua, and (site 3) infectious cells in maternal
blood to endothelial cells and endovascular cytotropho-
blasts. In the hematogenous route, CMV virions, possibly
coated by antibodies to virion envelope glycoproteins,
could undergo transcytosis to cytotrophoblast stem cells
via the neonatal Fc receptor (Fig. 1A, zone 1) or differen-
tiating cytotrophoblasts (Fig. 1A, zones II and III) under-
neath the syncytiotrophoblast surface. In the ascending
route, virus replicating in the cervical epithelium could
reach into the upper portions of the uterus and infect
susceptible cells in the decidua and glands (Fig. 1A,
zones IV and V). CMV infection of the placenta could
occur when invasive cytotrophoblasts encounter infected
maternal blood cells in the uterine wall (Fig. 1A, zones IV
and V) or when endovascular cytotrophoblasts breach
the maternal microvasculature, forming intimate contacts
with infected endothelial cells (Fig. 1B). In either case,
infections of adjacent cytotrophoblasts could transmit
the virus in a retrograde fashion to the placenta.
In this study, we sought to identify the cell types
capable of transmitting CMV infection in uterine blood
vessels at the maternal–fetal interface. To achieve this
goal, we developed an in vitro model of viral spread in
which polarized uterine microvascular endothelial cells
(UtMVEC) are cocultured with CMV-infected neutrophils
and differentiating/invasive cytotrophoblasts from early
gestation placentas (8–18 weeks). Our findings implicate
endothelial cells in the hybrid fetal-microvasculature as a
source for CMV infection of cytotrophoblasts in anchor-
ing villi that attach the developing placenta to the uterine
wall.
RESULTS
Lytic replication of VR1814-infected endothelial cells
The vascular bed of origin (e.g., aortic vs microcapil-
lary), endothelial cell–tropic properties, and the genetic
composition of clinical CMV strains determine whether
infected endothelial cells undergo lytic replication or
persistent infection in vitro (Fish et al., 1998; Kahl et al.,
2000; Revello et al., 2001; Sinzger et al., 1999). In the first
set of experiments, we evaluated the susceptibility of
endothelial cells derived from vessels in different tissues
including human uterine microvasculature (UtMVEC),
umbilical artery (HUAEC), umbilical vein (HUVEC), and
lung microvasculature (HMVEC-L) to infection with an
endothelial cell–tropic clinical strain of CMV, VR1814.
Cells were grown under nonpolar conditions and in-
fected with CMV strain VR1814. Results showed that
titers of intracellular virions and virus released into the
medium were highest in UtMVEC followed by HUAEC,
HUVEC, and HMVEC-L (Table 1).
Next, we examined VR1814 infection of UtMVEC, the
most productive type of cell, and HUVEC, the most fre-
quently used in studies of endothelial cells, in detail.
Immunostaining of the cells with rabbit antiserum to von
Willebrand factor (vWF) showed that UtMVEC cultures
were 98% endothelial cells (Fig. 2A). Immunofluores-
cence staining showed nuclear expression of CMV im-
TABLE 1
Infectious Viral Titers Produced in Endothelial Cells
from Blood Vessels in Different Organs
Endothelial cella
Titerb (log PFU/ml)
Intracellularc Extracellularc
UtMVEC 4.67 0.02 4.36 0.01
HUAEC 3.58 0.03 3.43 0.03
HUVEC 2.62 0.02 2.56 0.01
HMVEC-L 2.36 0.02 2.30 0.01
a Endothelial cells from human uterine microvasculature (UtMVEC),
umbilical artery (HUAEC), umbilical vein (HUVEC) and lung microvas-
culature (HMVEC-L).
b Cells were grown under nonpolar conditions, then infected with
endothelial cell-tropic CMV strain VR1814 (1 PFU/cell). Titers were
determined at 7 days postinfection in HF.
c Intracellular, cell-associated progeny virions; extracellular, progeny
virions released into culture medium.
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mediate-early nuclear proteins 1 and 2 (IE1&2) 24–48 h
after infection (Fig. 2B); by 96 h, glycoprotein B (gB) was
expressed and distributed in a cytoplasmic punctate
staining pattern that suggested a vesicular location (Fig.
2C). Titers of intracellular virus and virus released into
the medium were monitored 3–13 days after infection of
UtMVEC and HUVEC grown under nonpolar conditions
(Fig. 2D). Peak titers of intracellular virus were twofold
higher in UtMVEC than in HUVEC (4.7–4.9 vs 2.6–3.1 log
PFU/ml). HUVEC released more progeny virions, but a
fraction of intracellular progeny was retained in UtMVEC
(0.5–0.9 log PFU/ml). Although most UtMVEC became
infected, the cultures were not completely lysed at day
13, and a balance between cell lysis and growth of
uninfected cells was observed. UtMVEC formed larger
plaques than HUVEC, which could explain the higher
viral titers found in UtMVEC (data not shown). These
results indicated that VR1814 replicates efficiently in Ut-
MVEC, progeny virions are released, and viral titers are
higher than in HUVEC, suggesting that endothelial cells
from the uterine microvasculature may be a better host
cell for CMV infection than those from umbilical vein.
VR1814 preferentially infects polarized UtMVEC from
the apical membrane and disrupts intercellular
junctions
Polarized retinal pigment epithelial cells (ARPE-19) on
permeable filters are susceptible to CMV infection from
the apical surface, whereas herpes simplex virus (HSV-1)
infection occurs from both apical and basolateral mem-
branes (Tugizov et al., 1996). To determine how CMV
crosses the endothelial cell lumen of blood vessels, we
analyzed the susceptibility of polarized UtMVEC to infec-
tion. To form distinct apical and basolateral membranes
separated by tight junctions, cells were cultured on per-
meable Transwell filters, and the transcellular electrical
resistance was monitored. At 10–14 days, polarized
monolayers had formed, and key proteins were assem-
bled into tight junctions and adherens junctions that
stained in a specific immunofluorescence pattern. UtM-
VEC showed a delicate pattern of human zonula occlu-
dens (ZO-1) and occludin staining colocalized at inter-
cellular tight junctions (data not shown). VE-cadherin and
-catenin colocalized at the cell periphery in a continu-
FIG. 2. UtMVEC are fully permissive for CMV infection in vitro. (A) At the time of infection, 98% of the cells immunostained for vWF. UtMVEC and
HUVEC were infected with CMV strain VR1814. (B, C) Infected UtMVEC were stained for expression of IE1&2 and gB at 48 and 96 h postinfection.
Anti-IE1&2 antibody reacted with the nuclei (B, C), and anti-gB antibody showed granulated cytoplasmic staining (C). (D) Infected culture medium
(released virions) and cells (intracellular virus) were harvested at the indicated times, and viral titers were determined by a rapid infectivity assay on
HF. Values are the mean  SEM of three independent experiments.
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ous ribbon-like pattern in adherens junctions (Figs. 3A
and 3B), as did - and -catenin (data not shown).
To infect polarized UtMVEC, cell-free VR1814 stock
virus was applied to the apical and basolateral mem-
branes, and rapid infectivity assays were performed. The
cells were highly susceptible to apical infection but not
to basolateral infection. At 7 days after infection, 2.0- to
2.8-fold more virus was released into the upper chamber
than into the lower chamber (data not shown). Despite
repeated attempts, addition of 100-fold higher viral titers
to the basolateral membrane failed to infect polarized
endothelial cells. To determine whether virions could
access the cells through the filter pores, polarized UtM-
VEC were infected from the basolateral membrane with
HSV-1 (1 and 10 PFU/cell), a virus of comparable size to
CMV. The cells were fixed, and infection was evaluated
FIG. 3. CMV infection disrupts adhesion junction complexes in polarized UtMVEC. The cells were grown on permeable filters until polarized (A, B)
and infected with CMV strain VR1814. At 2 weeks after infection, cells were costained for CMV gB (C, D), VE-cadherin (E), and -catenin (F). -Catenin
closely followed the pattern observed for VE-cadherin and was abundantly expressed at lateral junctions (A, B). In viral plaques, gB showed strong
globular perinuclear staining (C, D, white arrows). Plaque formation was associated with a loss of VE-cadherin and -catenin staining (E, F). In
contrast, uninfected (gB-negative) UtMVEC that surrounded the plaque (demarcated by a dashed line) stained for VE-cadherin and -catenin (black
arrows).
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by immunolocalization of infected cell protein 4, the
HSV-1 immediate-early protein. Approximately 5–10% of
cells were infected with 1 PFU/cell and 60–70% with 10
PFU/cell (data not shown). Additional experiments in
which the polarized UtMVEC monolayers were scratched
and then infected with cell-free VR1814 showed that
endothelial cells in the outgrowth into the damaged area
were more readily infected than cells in undamaged
areas (data not shown). These findings suggest that
endothelial cell receptors for cell-free CMV virions were
expressed on apical membranes and that infection was
readily transmitted to nonpolarized endothelial cells
growing into damaged areas.
CMV infection slowly permeabilizes the tight junctions
of polarized epithelial cells, reducing the resistance and
increasing paracellular permeability (Tugizov et al.,
1996). Next, we examined the distribution of junction
proteins in polarized UtMVEC after infection with cell-
free VR1814 or with infectious, transmigrating neutro-
phils. The cells were fixed 2 weeks after plaque devel-
opment, stained for adherens junction proteins and CMV
gB, and analyzed by confocal microscopy. In viral
plaques, strong gB staining was noted (Figs. 3C, 3D) that
corresponded to a loss of VE-cadherin and -catenin
staining at cellular junctions in the infected cells. In
uninfected cells bordering the plaque, the distribution of
junction proteins was not altered (Figs. 3E, 3F). Immuno-
staining for ZO-1, occludin, and - and -catenin yielded
similar results (data not shown). These findings indicated
that CMV infection disrupts endothelial cell tight junc-
tions and VE–cadherin protein complexes that function
as a barrier to paracellular transport. To confirm the
observation that CMV perturbs the polarity of endothelial
cells, we measured the paracellular permeability of in-
fected UtMVEC (1 PFU/cell) and quantified the transmi-
gration of peroxidase-conjugated anti-mouse IgG (Fab)2
across the monolayer. At 7 days after infection, transmi-
gration was increased 10-fold. The changes in paracel-
lular permeability correlated with immunofluorescence
microscopy results and reflected a breach of the endo-
thelial cell barrier after CMV infection.
Disruption of junctional complexes induces
proliferation of endothelial cells adjacent to viral
plaques
Perturbation of endothelial cell junctions by treatment
with antibody to VE-cadherin induces its redistribution,
alters adherens junction integrity (Corada et al., 1999),
and induces cells to enter the S phase (Caveda et al.,
1996; Dejana, 1996; Lampugnani et al., 1995). To deter-
mine whether disruption of endothelial junctions might
explain the observed balance between the lysis of in-
fected endothelial cells and the regeneration of unin-
fected cells, polarized HUVEC were treated with mono-
clonal antibody (MAb) to VE-cadherin and immuno-
stained with MAb against bromodeoxyuridine (BrdU) to
detect S-phase cells. Untreated cells failed to take up
BrdU (Fig. 4A); however, cells treated with increasing
concentrations of anti-VE-cadherin showed a significant
number of S-phase cells (Fig. 4B, C), indicating that
disruption of adherens junction complexes itself triggers
proliferation of uninfected HUVEC.
Next, polarized HUVEC were infected with CMV, la-
beled with BrdU, fixed, and costained for BrdU and CMV
gB. In serial Z-sections from the apical level, we detected
infected cells with pycnotic nuclei that had incorporated
BrdU and expressed CMV gB (Figs. 4D--4F). In sections
from the basolateral level, uninfected BrdU-positive cells
with well-formed nuclei were interspersed throughout
the plaque and periphery (Figs. 4G--4L). In some regions,
nuclear and gB immunostaining were absent, suggesting
detachment of infected cells (Fig. 4I, asterisk). Experi-
ments with infected UtMVEC showed that these plaques
also contained proliferating cells. Medium from these
cultures contained infected endothelial cells that formed
plaques when plated on uninfected human foreskin fi-
broblasts (HF) (see below). These findings suggest that
CMV infection does not lyse all the cells in foci of polar-
ized endothelial cells, as indicated by the proliferation of
adherent cells that replaced detached infected cells.
Neutralizing antibodies to CMV gB inhibit viral
transmission in polarized endothelial cells
Potent neutralizing antibodies to CMV gB (a major
component of the virion envelope that promotes viral
penetration into cells) reduce plaque formation in CMV-
infected HF (Navarro et al., 1993) but fail to block viral
spread across intercellular junctions in infected polar-
ized ARPE-19 cells (Tugizov et al., 1996). To assess the
effects of neutralizing MAb to CMV gB on viral transmis-
sion in polarized HUVEC and UtMVEC grown on filter
supports, the cells were infected with VR1814 and main-
tained in medium with neutralizing MAb to CMV gB or
control MAb. The antibody-containing medium was
FIG. 4. CMV infection enhances the proliferation of uninfected endothelial cells in regions adjacent to viral plaques. Polarized HUVEC grown on
filters (A) were treated with 100 g/ml (B) and 200 g/ml (C) mouse MAb to VE-cadherin. After 1 h of incubation at 37°C, cells were labeled with BrdU
solution and immunostained with mouse MAb to BrdU. (D–I) Polarized HUVEC were infected and labeled with BrdU solution at 12 days and
immunostained with anti-BrdU MAb and guinea pig anti-CMV gB antiserum. Serial Z-sections in the x-y, horizontal plane were taken from the apical
(AP) and basolateral (BL) surfaces on a laser scanning confocal microscope; the rhodamine and FITC channels were acquired sequentially to prevent
bleed-through and subsequently merged. Asterisk indicates absence of gB staining resulting from detachment of infected cells. White arrow,
gB-expressing cell; black arrow, S-phase (BrdU-positive) cell.
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changed every other day for 2 weeks. The cells were
then fixed and stained with immunofluorescent guinea
pig anti-gB antiserum. Neutralizing MAb reduced the
number of infected cells in plaques by approximately
90% (Fig. 5A). In the presence of control MAb, the
plaques that formed in UtMVEC were typically large
(20–25 cells) (Fig. 5B), and those in HUVEC were larger
(100–120 cells) (Fig. 5D). In the presence of neutralizing
MAb, however, very small foci of infection formed, con-
taining 2–10 cells in both UtMVEC and HUVEC (Figs. 5C,
5E). These data suggest that viral spread occurs by virion
release and infection of adjacent cells and that the low
transelectrical resistance of polarized HUVEC facilitates
virus release and plaque formation in contrast to more
highly polarized UtMVEC.
Circulating infected endothelial cells are detected in
disseminated CMV infections with organ involvement
and might transmit virus to distant sites (Percivalle et
al., 1993). Therefore, we examined the effect of neu-
tralizing MAb on CMV transmission from detached
infected UtMVEC. Infected cells were cultured for 6
days to reach high titers in the presence of neutraliz-
ing and negative control MAbs. At 7 days postinfec-
tion, the culture medium containing infected endothe-
lial cells was transferred to a fresh confluent mono-
layer of UtMVEC and HF for 48 h, and infection was
monitored by immunofluorescence staining of CMV
IE1&2 and gB. In the presence of control MAb, de-
tached infected cells infected both UtMVEC (mean
0.523  0.06%) and HF (mean 27  0.28%), indicating
that the detached endothelial cells shed virus. CMV-
infected endothelial cells that adhered to the surface
of cells in the monolayer were distinguished by their
pycnotic appearance, IE1&2-positive nuclei, and ve-
sicular staining for gB in the cytoplasm (data not
shown). Approximately three to five recipient cells in
infected foci were observed as indicated by IE1&2
protein expression, and these cells were found in
close proximity to the adherent infected cells. These
experiments were repeated three times and the re-
sults support those of virus release summarized in
Table 1. In the presence of neutralizing MAb, UtMVEC
were not infected, and only a trace of infection
(0.074  0.01%) was observed in the HF monolayer.
These results show that neutralizing antibodies signif-
icantly limit plaque size in polarized infected endothe-
lial cells, suggesting that infection occurs by virion
release before attachment and penetration of neigh-
boring cells. Similarly, virions released from detached
infected endothelial cells readily spread to uninfected
cells. The finding that a potent neutralizing antibody to
CMV gB significantly reduces viral spread in umbilical
and uterine endothelial cells has important conse-
quences for limiting infection in utero.
UtMVEC transmit CMV infection to differentiating
cytotrophoblasts
To investigate potential routes of infection at the fetal–
maternal interface, specifically where invasive/differenti-
ating cytotrophoblasts form hybrid fetal–maternal ves-
sels, we examined CMV transmission from infectious
neutrophils to UtMVEC and invasive cytotrophoblasts,
using confocal microscopy to examine neutrophil inter-
actions with these cells. Four types of experiments were
done. First, we incubated pp65-positive neutrophils with
explants of floating and anchoring villi (see Fig. 1). No
infection was observed in three independent experi-
ments (data not shown). Second, we examined viral
spread from neutrophils to differentiating cytotropho-
blasts. Infectious neutrophil cultures that contained CMV
pp65-positive cells (5–10%) were generated in vitro and
incubated for 24–48 h with purified differentiating cytotro-
phoblasts. Infection was evaluated by immunofluores-
cence with anti-IE1&2 MAb. Despite many attempts (i.e.,
six independent preparations of infectious neutrophils
that were cocultured with cells from nine different pla-
centas), we failed to achieve cytotrophoblast infection
(data not shown) under experimental conditions that con-
sistently resulted in infection of UtMVEC and HUVEC
cocultured in parallel.
Third, polarized UtMVEC and HUVEC were cocultured
on permeable filters for 24 h with CMV-positive neutro-
phils generated in vitro, fixed, and costained with MAbs
to the CMV proteins pp65 and IE1&2 and to VE-cadherin
(Figs. 6A–6C). Infectious neutrophils appeared to transmi-
grate across the polarized UtMVEC monolayer from the
apical toward the basolateral compartment (Figs. 6D–6F),
infecting UtMVEC they came into contact with (Figs. 6G–6I).
After longer incubation periods, plaques formed in infected
UtMVEC and HUVEC (data not shown).
Fourth, UtMVEC were plated on Matrigel-coated filters
and infected with VR1814 (0.1–1 PFU/cell). After 7 days,
differentiating cytotrophoblasts (2.5  105 cells) were
added, and the cocultures were incubated for 72 h and
coimmunostained with MAbs to CMV IE1&2, cytokeratin,
and vWF. CMV infection was transmitted from UtMVEC to
cytotrophoblasts that stained with anti-IE1&2 (Figs. 6J–
6L). Cytotrophoblasts were reproducibly infected when
cocultured with infected endothelial cells. The efficiency
of cytotrophoblast infection was 10–30% and was directly
proportional to the number of infected endothelial cells.
Other experiments with cocultured cytotrophoblasts
showed that infection efficiency was lower when they
were cocultured with infected UtMVEC for 4 days (data
not shown). Likewise, addition of a single neutralizing
MAb to the cocultures reduced CMV infection of cytotro-
phoblasts by about one-half, suggesting that cell-free
released virus can transmit infection (data not shown).
These experiments indicated that CMV spreads from
infectious neutrophils to polarized UtMVEC, but not to
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FIG. 5. Neutralizing antibody to CMV gB reduces the development of viral plaques in infected polarized endothelial cells. UtMVEC and HUVEC were
grown on filters until polarized and were then infected from the apical membrane domain. The medium, containing affinity-purified neutralizing MAb
to the ectodomain of CMV gB, was applied to both apical and basolateral surfaces and was changed every second day for 2 weeks (C, E).
Nonneutralizing MAb to the cytoplasmic tail of CMV gB was used as a negative control (B, D). Two weeks after infection, cells were immunostained
with guinea pig anti-gB antiserum, and the number of cells in the plaques was counted (A). Values are the mean  SEM of three independent
experiments.
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cytotrophoblasts in vitro. Instead, cytotrophoblasts were
infected by direct contact with UtMVEC or released viri-
ons, and neutralizing antibodies reduced viral transmis-
sion.
DISCUSSION
In this study, we evaluated the potential role of neu-
trophils and endothelial cells in the spread of CMV in-
fection with an endothelial cell–tropic strain, VR1814, to
differentiating cytotrophoblasts in an in vitro coculture
model of viral spread. CMV infection of polarized UtM-
VEC with cell-free virus occurred predominantly from the
apical surface, disrupting intercellular junctions during
infection and subsequently increasing paracellular per-
meability and viral release in a nonpolar fashion.
Plaques that formed in polarized UtMVEC contained di-
viding uninfected cells that replaced CMV-infected cells
that had detached from the monolayer. Infectious neu-
trophils transmitted virus to polarized UtMVEC by trans-
migration from the apical surface across the endothelial
cell barrier. Notably, CMV-infected UtMVEC, but not in-
fectious neutrophils, had the capacity to infect differen-
tiating cytotrophoblasts. Neutralizing antibodies to CMV
gB effectively limited plaque formation in polarized UtM-
VEC, thereby reducing viral spread to differentiating/
invasive cytotrophoblasts. These findings suggest that
CMV transmission can occur by virion release from in-
fected endothelium at the fetal–maternal interface and
that virus-neutralizing antibodies can modulate CMV
spread to endovascular cytotrophoblasts.
Immunohistochemical analyses showed that endothe-
lial cells are targets of CMV in infected organs (Sinzger
et al., 1993, 1995), suggesting that leukocytes and endo-
thelial cells can participate in hematogenous viral trans-
mission in acutely infected and immunocompromised
patients (Gerna et al., 2000; Grefte et al., 1993a; Grundy
et al., 1998; Percivalle et al., 1993). Infected endothelial
cells may trigger direct vascular injury, including damage
of microvascular endothelium, vasculitis, thrombotic oc-
clusion, and hemorrhages (Persoons et al., 1998). At
sites of inflammation or infection, circulating leukocytes
in the bloodstream recognize and adhere to endothe-
lium, facilitated by integrins and adhesion molecules
(Berton and Lowell, 1999). Recently it was demonstrated
that CMV virions in neutrophils are transferred from in-
fected endothelial cells (Grundy et al., 1998; Revello et
al., 1998). Although replication is abortive in neutrophils,
it is thought that infectious virions can be transmitted to
endothelial cells through microfusion events at the
plasma membrane (Gerna et al., 2000).
Our results in this study support a potential role for
endothelial cells in CMV transmission from the uterine
wall to endovascular cytotrophoblasts in anchoring villi
of the placenta. Unexpectedly, neutrophils did not directly
infect differentiating cytotrophoblasts that switch from an
epithelial to an endothelial cell phenotype during remod-
eling of maternal vessels (Damsky and Fisher, 1998).
Invasive cytotrophoblasts have reduced expression of
adhesion receptors characteristic of cytotrophoblast ep-
ithelial stem cells (integrin 64 and E-cadherin) and
increased expression of adhesion receptors character-
istic of endothelium (VE-cadherin, the IgG-family recep-
tor vascular cell adhesion molecule-1, platelet-endothe-
lial cell adhesion molecule-1, and integrins V3 and
11). Invasive cytotrophoblasts abundantly express an-
other characteristic receptor of endothelium, intercellular
adhesion molecule-1 (O. Genbacev, E. Maidji, S. Fisher,
and L. Pereira, unpublished observations) that could pro-
mote viral spread from neutrophils to endothelial cells
(Gerna et al., 2000). Although neutrophils failed to trans-
mit infection to cytotrophoblasts in vitro, the microenvi-
ronment in utero differs considerably with respect to
blood flow in uterine vessels, placental growth factors
(Bass et al., 1994), and immune mediators such as che-
mokines, cytokines, and their receptors (Drake et al.,
2001; Red-Horse et al., 2001) that could attract immune
cells and enhance their adhesion and de novo expres-
sion of cell-surface molecules that could serve as CMV
receptors.
In support of in vivo studies (Gerna et al., 1998; Per-
civalle et al., 1993; Vossen et al., 1996), we observed
detachment of infected UtMVEC from polarized monolay-
ers in vitro and found that uninfected cells proliferate to
repair the gaps. Infection with a clinical CMV isolate
reduces the ability of endothelial cells to bind fibronectin,
collagen type IV, and laminin by selectively altering inte-
grin expression (Shahgasempour et al., 1997). Thus, it
was intriguing to consider the effect of CMV infection on
the proliferative activity of infected endothelial cells and
uninfected cells adjacent to viral plaques. Although CMV
causes cell-cycle arrest, cells that are infected near or
during the S-phase undergo mitosis before arrest (Sal-
FIG. 6. Infected UtMVEC transmit CMV to differentiating/invasive cytotrophoblasts. Infectious (pp65-positive) neutrophils (white arrow) were
cocultured with polarized UtMVEC (black arrows) on permeable filters for 1 h, fixed, and stained with anti-CMV pp65 (green), anti-VE-cadherin (green),
and propidium iodide (nuclei, red). After transendothelial migration, cells were stained with mouse MAbs to CMV pp65 and IE1&2 (green) and with
propidium iodide (nuclei, red). Serial Z-sections in the x-y (horizontal) plane (A–C, G–I) and x-z (vertical) plane (D–F) were taken on a laser scanning
confocal microscope; the rhodamine and FITC channels were acquired sequentially to prevent bleed-through and subsequently merged. (J–L) Purified
cytotrophoblasts (CTB, white arrowhead) were cocultivated with infected UtMVEC (black arrow) for 48 h and immunostained for expression of CMV
IE1&2 (green), cytotrophoblast cytokeratin (CK, red), and vWF (blue). Serial Z-sections were taken in the x-y plane (J, L) and the x-z plane (K).
Rhodamine, FITC, and Cy-5 channels were acquired sequentially to prevent bleed-through and subsequently merged.
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vant et al., 1998). Our finding that some infected cells
incorporated BrdU support these observations. We also
detected uninfected S-phase cells that had incorporated
BrdU at the basal level primarily in regions where gaps
had formed because of cell detachment. As noted in
studies of HUVEC (Kahl et al., 2000; Sinzger et al., 1997),
UtMVEC infected with an endothelial cell–tropic viral
strain were not completely lysed and formed viral
plaques on HF. Since junction complexes of polarized
endothelial cells are disrupted by CMV infection or by
anti-VE-cadherin alone, triggering cell proliferation, our
data suggest that changes in the adhesion milieu of
adjacent uninfected cells induced some cells to undergo
mitosis. This possibility is consistent with a balance
between lysis of infected endothelial cells and replace-
ment by uninfected ones (Kahl et al., 2000).
Microvascular endothelial cells from organs that are
subjected to significant changes in pressure and shear
(heart, lungs) or are hormone responsive (uterus, testes)
express different cell-surface receptors and form differ-
ent adherens junctions than those from organs not sub-
ject to such changes. Differences in susceptibility to
CMV infection were also found among endothelial cells
with organ-specific properties that originate from differ-
ent organs such that endothelial cells from the uterus
produced higher viral titers, followed by umbilical artery,
umbilical vein, and lung (see Table 1) (Blum et al., 1997;
Cantarella et al., 2001; Kastin et al., 2001; Petzelbauer et
al., 1993; Rupnow et al., 2002; Toth, 2001; Wilson et al.,
2001). In vivo, the integrity of adherens junctions of mi-
crovascular endothelial cells is determined in large part
by VE-cadherin (Corada et al., 1999). We found that CMV
forms larger plaques in nonpolarized UtMVEC than in
polarized ones, whereas plaques formed in polarized
monolayers were smaller in UtMVEC than in HUVEC (Fig.
5). As the transelectrical resistance of polarized uterine
microvascular cells is higher, the junctions formed might
be less permeable to virus release than cells from the
umbilical vein. Similarly, CMV-infected foci in polarized
epithelial cells, ARPE-19, are very small compared to
those in nonpolar cells (Maidji et al., 1996; Pereira et al.,
1995). Our results suggest that the endothelial and epi-
thelial cell origin, extent of polarity, and ability of CMV
strains to permeabilize junctions affect virus spread.
Our findings suggest that the interface between inva-
sive cytotrophoblasts and endothelial cells in remodeled
uterine vessels where cytotrophoblasts replace the en-
dothelial lumen and muscle cells could be an ideal
locale for CMV replication. During symptomatic CMV
infection in immunocompromised individuals, it is
thought that infected macrophages (Bolovan-Fritts et al.,
1999; Hahn et al., 1998; Kondo et al., 1996), reactivated
latent virus (Soderberg-Naucler et al., 1997, 2001), and
neutrophils disseminate infection to endothelial cells
(Grefte et al., 1993b; Revello et al., 1998). This could occur
at the fetal–maternal interface, where cytotrophoblasts
produce many cytokines (Drake et al., 2001; Red-Horse
et al., 2001) and interleukin-10 (Roth et al., 1996). In
summary, we suggest that viral progeny from CMV-in-
fected UtMVEC transmitted to cytotrophoblasts could
spread infection in a retrograde direction to the placenta
proper (i.e., floating chorionic villi) and to fetal blood
vessels in the villus core.
It is important to consider that vertical transmission is
reduced in women with preexisting immunity to CMV, as
indicated by seropositivity before pregnancy (Adler, 1995;
Fowler et al., 1992). On the other hand, recent analyses
indicate that seropositive women, especially those with
low-avidity antibodies to CMV gB and those with neutral-
izing antibodies who are reinfected with new CMV
strains, transmit infection that could cause congenital
disease (Boppana and Britt, 1995; Boppana et al., , 1996,
1999, 2001). Consequently, a unique property of CMV as
an infectious agent is that serological immunity prior to
conception dramatically decreases infection in most
women, but does not completely prevent vertical trans-
mission (Britt, 1999). Although the route of symptomatic
prenatal infection is poorly defined, in most cases neu-
tralizing antibodies that have access to the site of infec-
tion limit dissemination of CMV to the fetus. Our findings
in this study indicate that neutralizing gB-specific anti-
bodies reduce the level of virus released from infected
UtMVEC and limit dissemination to invasive endovascu-
lar cytotrophoblasts. Conceivably, local infections in hy-
brid fetal–maternal blood vessels could be limited by
high titers of anti-CMV neutralizing antibodies. In con-
trast, infections in the cervical or luminal epithelium or in
the uterine decidua from trafficking macrophage/den-
dritic cells that reactivate virus are most likely seques-
tered from neutralizing antibodies. Gaining a deeper un-
derstanding of the routes and cell types that transmit
CMV infection to the placenta is the first step in reducing
prenatal infection. Our findings in this study support
immunization strategies that generate humoral immunity
to CMV that could reduce infection of placental endovas-
cular cytotrophoblasts in contact with maternal blood.
MATERIALS AND METHODS
Cell culture
HUVEC, UtMVEC, HUAEC, and HMVEC-L were pur-
chased from Clonetics (BioWhittaker) and maintained
with EGM-2-MV BulletKit (Clonetics). Cells from pas-
sages 2–8 were used for experiments. The purity of
endothelial cells was verified in each passage by immu-
nofluorescence staining of paraformaldehyde-fixed slide
cultures with a rabbit antiserum to vWF complex (Novo-
castra Laboratories). To form polarized monolayers, the
cells (104 cells/cm2) were seeded on 12-mm-diameter
permeable filters (0.45 m pore size, Transwell; Costar)
coated with fibronectin (10 g/cm2; Sigma) and main-
tained for 2–4 weeks. The formation of confluent mono-
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layers was monitored by staining the cells with acridine
orange. HF were maintained in Dulbecco’s modified Ea-
gle’s medium (DMEM) (Life Technologies) containing
10% NU-serum (Becton–Dickinson), 200 mM L-glutamine
(Sigma), 0.1 mg/ml streptomycin, and 100 units/ml peni-
cillin (Sigma). Highly purified cytotrophoblasts were iso-
lated from early gestation placentas (8–18 weeks) as
described (Librach et al., 1991). To control for infection in
utero, cells (5  104) were immobilized on slides by
centrifugation (Cytospin Cell Preparation System; Shan-
don), fixed, and stained with antibodies specific for
IE1&2. Cytotrophoblasts were resuspended in DMEM
containing 2% Nutridoma (Boehringer Mannheim Corp.)
Viral infection and titration
VR1814, an endothelial cell–tropic clinical strain of
CMV isolated from the cervix, was adapted for growth in
HUVEC (Revello et al., 2001). HUVEC were infected in
EBM Basal Medium (Clonetics) containing 1% fetal bo-
vine serum (HyClone) for 1 h; the inoculum was then
removed and replaced with fresh medium. Intracellular
viral titers were determined with a rapid immunofluores-
cence-based infectivity assay in HF (Andreoni et al.,
1989; Navarro et al., 1993). HSV-1 strain F was propa-
gated and titered in Vero cells (Ejercito et al., 1968).
UtMVEC and HUVEC grown on permeable filter supports
were infected by adding CMV stock inoculum to the
upper (apical infection, 0.1 PFU/cell) and lower (basolat-
eral infection, 10 PFU/cell) filter chambers, as described
for polarized ARPE-19 cells (Tugizov et al., 1996). Infec-
tious virions released into the medium from apical and
basolateral surfaces were titered as described above.
Preparation of infectious neutrophils
Concentrated neutrophils (3  107) from healthy blood
donors were prepared as described (Revello et al., 1998)
and cocultured for 12 h with HUVEC infected with VR1814
(1 PFU/cell) at 96–144 h. To obtain a uniform neutrophil
preparation, nonadherent cells were aspirated from in-
fected HUVEC, and cells (107) were applied to the upper
compartment of filter inserts (5-m pore size, Transwell;
Costar). After 3 h, the number of pp65-positive infectious
neutrophils (5–10% of the total number) that transmi-
grated to the lower compartment toward medium con-
taining the attractant (108 M formyl-methionyl-leucyl-
phenylalanine (FMLP), Sigma) was evaluated in a neu-
trophil cytospin preparation. Cells were fixed with 5%
formaldehyde, permeabilized with 0.5% Nonidet P-40,
and reacted with MAb to pp65. Infectious neutrophils
obtained after coculture were quantified by inoculating
HF monolayers with 2  105 neutrophils and counting
the number of HF nuclei stained with MAb CH160 to
CMV IE1&2 24 h after infection.
Antibodies
Mouse MAbs to selected CMV proteins—CH160–5 to
IE1&2 (open reading frames UL122, UL123), CH65 to
matrix protein pp65 (UL83), CH177 to gB (UL55), and MAb
to H640 to HSV-1 infected cell protein 4—were gener-
ated in the Pereira laboratory as described (Ackermann
et al., 1984; Dondero and Pereira, 1990; Pereira et al.,
1982, 1984). The neutralizing properties of CH177 for
CMV strain AD169 have been reported (Qadri et al., 1992;
Tugizov et al., 1994). Purified IgG was obtained from the
Goodwin Institute (Plantation, FL). Guinea pig antiserum
to CMV gB was a generous gift from Chiron Corp. The
antiendothelial cell antibodies were a mouse anti-human
MAb to intercellular adhesion molecule-1 (CD54; R&D
Systems), a mouse anti-human MAb to VE-cadherin (In-
noGenex), and a rabbit polyclonal anti-human MAb to
vWF (Novocastra Laboratories). Rat anti-trophoblast
MAb to cytokeratin 7D3 was produced in the Fisher
laboratory as described (Damsky et al., 1992). Antibodies
to the junctional complex proteins were mouse mono-
clonal anti-mouse -catenin, anti-mouse -catenin, and
anti-bovine -catenin (Transduction Laboratories), reac-
tive with their human counterparts, and rabbit polyclonal
anti-ZO-1 and anti-human occludin (Zymed Laboratories).
Mouse MAb to BrdU was purchased from Roche Diag-
nostics. The secondary antibodies (Jackson ImmunoRe-
search Laboratories) were goat anti-mouse IgG labeled
with fluorescein isothiocyanate (FITC), rhodamine
(TRITC), or cyanine (Cy-5); goat anti-rat IgG labeled with
rhodamine (TRITC); goat anti-guinea pig IgG labeled with
FITC; and goat anti-rabbit IgG labeled with rhodamine
(TRITC) or Cy-5.
Immunofluorescence laser scanning confocal
microscopy
For immunofluorescence assays, cells were fixed
with fresh 3% paraformaldehyde in phosphate-buff-
ered saline (PBS) (15 min) and permeabilized with 0.1%
Triton X-100 in PBS (5 min). After incubation with 50
mM NH4Cl (10 min) to quench paraformaldehyde, the
cells were incubated with primary antibody (1 h) and
then with secondary antibodies conjugated with FITC
or rhodamine (30 min). For double staining, cells were
simultaneously incubated with primary antibodies
from different species and secondary antibodies la-
beled with FITC, rhodamine, or Cy-5. Cells were ana-
lyzed with a krypton–argon laser coupled to a Bio-Rad
MRC1024 confocal head attached to an Optiphot II
Nikon microscope with a Plane Apo 60 1.4 objective
lens. Serial Z-sections of each field were captured
sequentially by using the same specifications and
separate excitation wavelengths to prevent bleed-
through between emission channels.
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Assay for transcellular electrical resistance
The transcellular electrical resistance of cells grown
on permeable Transwell filters (0.45 m) was monitored
by an electrical resistance system (Millicell-ERS Volto-
hmmeter, Millipore). The value obtained from a blank
insert coated with fibronectin was subtracted to give net
resistance, which was multiplied by the membrane area
to yield the resistance in area-corrected units. Maximum
resistance was usually reached 10–14 days after plating
on permeable Transwell filters as described above. Cells
were considered polarized when the resistance was
110–150 /cm2 (UtMVEC) or 20–30 /cm2 (HUVEC). The
polarity of UtMVEC and HUVEC was verified in parallel
by localization of cell junction proteins with immunoflu-
orescence confocal microscopy and by transendothelial
permeability assays.
Assay for transendothelial permeability
HUVEC and UtMVEC polarized on permeable filters
were infected with VR1814 (1 PFU/cell) from the apical
surface membrane. At 7 days after infection, the perme-
ability of infected and uninfected controls was assayed
as described (Gulino et al., 1998). Horseradish peroxi-
dase conjugated goat anti-mouse IgG (Fab)2 (Jackson
ImmunoResearch Laboratories) was added to the upper
filter compartment. After 1 h of incubation, the medium in
the lower compartment was assayed photometrically for
horseradish peroxidase with o-phenylenediamine dihy-
drochloride (Sigma) as the substrate.
Plaque formation in polarized endothelial cells
Polarized UtMVEC grown on filter supports were in-
fected from the apical membrane with cell-free virus or
with infectious neutrophils. Medium containing affinity-
purified IgG from mouse ascites containing neutralizing
MAb to gB, CH177 (40 g/ml), was applied to the apical
and basolateral surfaces of the cells and changed at
48-h intervals. Affinity-purified nonneutralizing IgG from
ascites containing MAb to the carboxyl terminus of gB,
CH28–2 (40 g/ml), was used as a negative control. At 12
days after infection, cells were fixed with 3% paraformal-
dehyde in PBS, permeabilized with 0.1% Triton X-100, and
reacted in immunofluorescence assays with a guinea pig
antiserum to CMV gB.
Cell proliferation assay
Polarized UtMVEC grown on filters were infected (0.1
PFU/cell) from the apical membrane as described above.
At 12 days after infection, cells were labeled with 10 M
BrdU solution, incubated for 24 h, fixed, and reacted in
immunofluorescence assays with mouse MAb to BrdU
and guinea pig antiserum to CMV gB. Cells were washed
and incubated with secondary antibodies labeled with
rhodamine and FITC, respectively.
Coculture of infectious neutrophils with endothelial
cells
Infectious neutrophils (106) were cocultured with po-
larized UtMVEC and HUVEC in the upper compartment of
filter inserts (3-m pore size, Transwell; Costar); the
lower compartment contained the attractant (FMLP). Af-
ter 1 h, 3 h, 24 h, and 5 days of coculture, the cells were
fixed with 3% paraformaldehyde and coimmunostained
with MAb CH160, CH65, and antibody to VE-cadherin to
identify CMV-infected endothelial cells.
Coculture of infectious neutrophils with
cytotrophoblasts
Infectious neutrophils were cocultured with VR1814-
infected HUVEC and a uniform infectious neutrophil pop-
ulation (5–10% pp65 positive) obtained as described
above. Cytotrophoblasts (2.5  105) purified from early
gestation placentas (8–18 weeks) were plated on Matri-
gel-coated filters as described (Fisher et al., 2000; Li-
brach et al., 1991). The cells were cocultured with pp65-
positive infectious neutrophils (106). After 1, 2, and 3 days
in coculture, the cells were fixed and costained with MAb
CH160 to CMV IE1&2 and rat MAb to cytokeratin in
cytotrophoblasts.
Coculture of infected UtMVEC with cytotrophoblasts
Subconfluent UtMVEC grown on filters (0.4-m pore
size) coated with Matrigel were infected with cell-free
VR1814 stock virus (0.5 PFU/cell) or incubated with pp65-
positive infectious neutrophils (106) purified as described
above. As evaluated by CMV gB expression, approxi-
mately 50% of the endothelial cells were infected after
5–7 days. Infected UtMVEC were cocultured for 3 days
with cytotrophoblasts (2.5  105) isolated as described
above. After 1, 2, and 3 days in coculture, the cells were
fixed and coimmunostained with MAb CH160 to CMV
IE1&2, rat MAb to cytokeratin, and a rabbit polyclonal
antiserum to human vWF in endothelial cells.
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